浏览全部资源
扫码关注微信
1.喀什地区第一人民医院感染科,新疆 喀什844000//中山大学附属第三医院感染科,广东 广州510630
2.喀什地区第一人民医院神经内科,新疆 喀什844000//中山大学附属第三医院神经内科,广东 广州510630
3.喀什地区第一人民医院放射科,新疆 喀什844000//中山大学附属第三医院放射科,广东 广州510630
4.喀什地区第一人民医院感染科,新疆 喀什844000
ZHU Jianyun; E-mail:zhujiany@mail.sysu.edu.cn
Published:20 July 2024,
Received:28 April 2024,
Accepted:25 May 2024
扫 描 看 全 文
潘淑芳,常艳宇,王晓红等.喀什地区神经型布鲁氏菌病的临床特征分析[J].中山大学学报(医学科学版),2024,45(04):649-656.
PAN Shufang,CHANG Yanyu,WANG Xiaohong,et al.Clinical Characterization of Neurobrucellosis in Kashi Region[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(04):649-656.
潘淑芳,常艳宇,王晓红等.喀什地区神经型布鲁氏菌病的临床特征分析[J].中山大学学报(医学科学版),2024,45(04):649-656. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240617.004.
PAN Shufang,CHANG Yanyu,WANG Xiaohong,et al.Clinical Characterization of Neurobrucellosis in Kashi Region[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(04):649-656. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240617.004.
目的
2
探讨喀什地区神经型布鲁氏菌病的临床特征,提高诊疗水平。
方法
2
对2019年12月至2024年1月喀什地区第一人民医院收治的18例神经型布鲁氏菌病患者的临床资料进行回顾性分析。
结果
2
18例神经型布鲁氏菌病患者中,男性9例,女性9例,中位年龄36(17~54.5)岁。所有患者均有布鲁氏菌病流行病学史。诊断为脑膜脑炎12例,脑膜炎5例,脑炎1例。其中2例患者合并脊髓膜炎。2例患者合并骨关节炎,1例患者合并附睾炎。最常见的临床表现是头痛、发热、乏力。虎红平板试验(RBPT)及试管凝集试验(SAT)的阳性比分别为11/12、8/9,血培养阳性比2/10,脑脊液培养阳性比4/16,脑脊液病原高通量测序(NGS)阳性比5/5。脑脊液呈渗出性改变,白细胞升高,以单个核细胞升高为主。所有患者均应用多西环素、利福平、头孢曲松、头孢克肟、左氧氟沙星、米诺环素或磺胺中的2~4种联合治疗。多数患者预后较好。
结论
2
来自布鲁菌病疫区的患者存在中枢神经系统表现需要考虑神经型布鲁菌病的可能性。当脑脊液出现渗出性改变时,可以通过结合布鲁氏菌血清学、血培养、脑脊液培养和NGS来鉴别其他病原体导致的中枢神经系统感染;NGS可以明显提高神经型布鲁菌病诊断率。
Objective
2
To explore the clinical characteristics of neurobrucellosis in Kashi, Xinjiang Uygur Autonomous Region, thus improve the diagnosis and treatment.
Methods
2
A retrospective analysis was conducted on the clinical data of 18 cases of neurobrucellosis who were admitted to the First People's Hospital of Kashi Prefecture between December 2019 and January 2024.
Results
2
The study included 9 males and 9 females, with a median age of 36 years (range: 17-54.5). A clear epidemiological history was found in all the 18 brucllosis patients, 12 of whom presented with meningoencephalitis, 5 meningitis, and 1 encephalitis. Two comorbided with spinal meningitis, 2 osteoarthritis and 1 epididymitis. Most frequently reported clinical symptoms were headache, fever and fatigue. The prevalence rates of brucellosis by rose bengal plate agglutination test (RBPT) and serum agglutination test (SAT) were 11/12 and 8/9, respectively. Two of 10 patients had positive blood cultures, four of 16 had positive cerebrospinal fluid (CSF) cultures and five of five were detected to be positive by next-generation sequencing (NGS) for pathogens in CSF. CSF showed exudative changes and elevated number of leukocytes, with predominance of single nucleated cells. All patients were treated with the combined use of two to four from the drugs like doxycycline, rifampicin, ceftriaxone, cefixime, minocycline, levofloxacin and sulfanilamide. Most patients had a favorable prognosis.
Conclusions
2
Neurobrucellosis should be considered in all patients with central nervous system manifestations from endemic areas. If there are exudative changes in CSF, differential diagnoses can be made by serological testing, blood culture, CSF culture and NGS. NGS could significantly increase the accuracy for neurobrucellosis diagnosis.
神经布鲁氏菌病布鲁氏菌病脑炎脑膜炎脑膜脑炎
neurobrucellosisBrucellosisencephalitismeningitismeningoencephalitis
中华人民共和国卫生部. 布鲁氏菌病诊疗指南(试行)[J]. 传染病信息, 2012, 25(6): 323-324;+359.
Ministry of Health of the People's Republic of China. Guidelines for the Diagnosis and Treatment of Brucellosis (Trial) [J]. Infect Dis Inform, 2012, 25(6): 323-324;+359.
《中华传染病杂志》编辑委员会. 布鲁菌病诊疗专家共识[J]. 中华传染病杂志, 2017, 35(12): 705-710.
Editorial Board of Chinese Journal of Infectious Diseases. Expert consensus on the diagnosis and treatment of brucellosis [J]. Chin J Infect Dis, 2017, 35(12): 705-710.
Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis[J]. PLoS Negl Trop Dis, 2012, 6(12): e1929.
Naderi H, Sheybani F, Parsa A, et al. Neurobrucellosis: report of 54 cases[J]. Trop Med Health, 2022, 50(1): 1-6.
Esmael A, Elsherif M, Elegezy M, et al. Cognitive impairment and neuropsychiatric manifestations of neurobrucellosis.[J]. Neurol Res, 2021, 43(1): 1-8.
Patra S, Kalwaje Eshwara V, Pai AR, et al. Evaluation of clinical, diagnostic features and therapeutic outcome of neurobrucellosis: a case series and review of literature[J]. Int J Neurosci, 2022, 132(11): 1080-1090.
Bodur H, Erbay A, Akinci E, et al. Neurobrucellosis in an endemic area of brucellosis[J]. Scand J Infect Dis, 2003,35(2):94-97.
Guven T, Ugurlu K, Ergonul O, et al. Neurobrucellosis: clinical and diagnostic features[J]. Clin Infect Dis, 2013, 56(10): 1407-1412.
蒋祯祥, 王童敏, 刘俊玲. 2001-2007年新疆喀什地区法定传染病疫情动态分析[J]. 疾病监测, 2009, 24(2): 121-123.
Jiang ZX, Wang TM, Liu JL. (2009). Dynamic analysis of statutory infectious disease epidemics in kashgar, Xinjiang from 2001 to 2007 [J]. Dis Surveill, 24(2): 121-123.
章文强,栾荣生. “One Health”和我国布鲁氏菌病防控[J].现代预防医学,2021,48(1):166-169.
Zhang WQ,Luan RS. Imperative “One Health” strategy for the prevention and control of brucellosis in China[J]. Modern Prevent Med,2021,48(1):166-169.
中华人民共和国卫生部. 布鲁氏菌病诊疗方案(2023年版)[EB]. https://m.medlive.cn/guide/1/30703https://m.medlive.cn/guide/1/30703.
Brucellosis diagnosis and treatment guidelines (Version 2023) [EB]. https://m.medlive.cn/guide/1/30703https://m.medlive.cn/guide/1/30703.
Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases[J]. Int J Infect Dis, 2009, 13(6): e339-e343.
Artuk C, Gul C. Complications and treatment of brucellosis: 11-year results[J]. Acta Med Medit, 2019, 35: 1311.
Araj GF. Update on laboratory diagnosis of human brucellosis[J]. Int J Antimicrob Agents, 2010, 36 Suppl 1:S12-S17.
地尔木拉提·吐孙, 麦维兰江·阿不力米提,刘振江,等2011-2020年新疆喀什地区肺结核流行特征分析[J]. 新疆医科大学学报,21(2): 93-97;+101.
Di'ermulati T, Maiweilanjiang A, Liu ZJ, et al. Analysis of the epidemic characteristics of pulmonary tuberculosis in kashgar, xinjiang from 2011 to 2020 [J]. J Xinjiang Med Univ, 21(2): 93-97;+101.
Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature[J]. Int J Infect Dis, 2010,14(6):e469-e478.
中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南[J].中华传染病杂志,2020,38(7):400-408.
Association TMC Of CT, Association CM. 2019 Chinese guidelines for the diagnosis and treatment of central nervous system tuberculosis[J]. Chin J Infect Dis, 2020, 38(7): 400-408.
中华医学会感染病学分会. 隐球菌性脑膜炎诊治专家共识 [J] . 中华传染病杂志, 2018, 36(4) : 193-199.
Chinese Medical Association, Infectious Diseases Society of China. Expert consensus on the diagnosis and treatment of Cryptococcal meningitis [J]. Chin J Infect Dis, 2018, 36(4):193-199.
Erdem H, Senbayrak S, Meriç K, et al. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study[J]. Infection, 2016, 44(5): 623-631.
Kizilkilic O, Calli C. Neurobrucellosis[J]. Neuroimaging Clinics, 2011, 21(4): 927-937.
Memish Z, Mah MW, Al Mahmoud S, et al. Brucella bacteraemia: clinical and laboratory observations in 160 patients[J]. J Infect, 2000,40(1):59-63.
Gotuzzo E, Carrillo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis--the value of bone marrow culture[J]. J Infect Dis, 1986,153(1):122-125.
Memish ZA, Almuneef M, Mah MW, et al. Comparison of the brucella standard agglutination test with the ELISA IgG and IgM in patients with Brucella bacteremia[J]. Diagn Microbiol Infect Dis, 2002, 44(2):129-132.
Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human Brucellosis[J]. Clin Microbiol Rev, 2019, 33(1):e00073-19.
Tajerian A, Sofian M, Zarinfar N, et al. Manifestations, complications, and treatment ofneurobrucellosis: a systematic review and meta-analysis[J]. Int J Neurosci, 2024, 134(3):256-266.
0
Views
4
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution